AGC Biologics and Horizon Therapeutics plc Expand Partnership
Horizon's TEPEZZA® (teprotumumab-trbw) treatment will be produced from AGC Biologics' new facility inBoulder, CO SEATTLE, Oct. 30, 2020 /PRNewswire/ -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced that its partnership wit...
2020-10-30 03:17
5036